{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:04:54Z","timestamp":1789085094208,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpain.2025.105380","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T18:16:04Z","timestamp":1743444964000},"page":"105380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["AK1780, a selective P2X7 receptor antagonist with high central nervous system penetration, exhibits analgesic effect in rat neuropathic pain model"],"prefix":"10.1016","volume":"31","author":[{"given":"Naomi","family":"Shinotsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4090-8371","authenticated-orcid":false,"given":"Hirotomo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Yamasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohide","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Fujiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2025.105380_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jpain.2025.105380_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.expneurol.2004.11.001","article-title":"Immune and glial cell factors as pain mediators and modulators","volume":"192","author":"McMahon","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2025.105380_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbi.2019.04.033","article-title":"Neuroimmune interactions in chronic pain \u2013 an interdisciplinary perspective","volume":"79","author":"Hore","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jpain.2025.105380_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","article-title":"Role of interleukin-1\u03b2 during pain and inflammation","volume":"60","author":"Ren","year":"2009","journal-title":"Brain Res Rev"},{"issue":"6","key":"10.1016\/j.jpain.2025.105380_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and therapeutic relevance of neuro-immune communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.jpain.2025.105380_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.expneurol.2011.11.012","article-title":"ATP receptors gate microglia signaling in neuropathic pain","volume":"234","author":"Trang","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2025.105380_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2020.11.030","article-title":"Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice","volume":"92","author":"Yi","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14496","article-title":"Involvement of microglial P2X7 receptor in pain modulation","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib13","first-page":"2788","article-title":"P2X and P2Y receptor antagonists reduce inflammation in ATP-induced microglia","volume":"21","author":"Imraish","year":"2023","journal-title":"Pharm Pract ((Granada))"},{"issue":"9","key":"10.1016\/j.jpain.2025.105380_bib14","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s11064-021-03516-6","article-title":"The role of ATP receptors in pain signaling","volume":"47","author":"Inoue","year":"2022","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11302-016-9537-0","article-title":"Microvesicles shed from microglia activated by the P2X7-p38 pathway are involved in neuropathic pain induced by spinal nerve ligation in rats","volume":"13","author":"Li","year":"2017","journal-title":"Purinergic Signal"},{"issue":"20","key":"10.1016\/j.jpain.2025.105380_bib16","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1523\/JNEUROSCI.5250-14.2015","article-title":"Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18","volume":"35","author":"Yang","year":"2015","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","article-title":"Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain","volume":"114","author":"Chessell","year":"2005","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jpain.2025.105380_bib18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.neuroscience.2007.03.035","article-title":"P2X7-related modulation of pathological nociception in rats","volume":"146","author":"McGaraughty","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [n-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpain.2025.105380_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0707266","article-title":"Novel P2X7 receptor antagonists ease the pain","volume":"151","author":"King","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2011.08.058","article-title":"Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model","volume":"504","author":"Kobayashi","year":"2011","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1523\/JNEUROSCI.3295-09.2010","article-title":"P2X7-dependent release of interleukin-1\u03b2 and nociception in the spinal cord following lipopolysaccharide","volume":"30","author":"Clark","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00574-1","article-title":"Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain","volume":"103","author":"Sweitzer","year":"2001","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2010.01.005","article-title":"The synaptic connectivity that underlies the noxious transmission and modulation within the superficial dorsal horn of the spinal cord","volume":"91","author":"Wu","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jpain.2025.105380_bib25","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.925491","article-title":"P2X7 Receptor (P2X7R) of microglia mediates neuroinflammation by regulating (NOD)-like receptor protein 3 (NLRP3) inflammasome-dependent inflammation after spinal cord injury","volume":"26","author":"Fan","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jpain.2025.105380_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejphar.2015.09.026","article-title":"A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334","volume":"765","author":"Lord","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.jpain.2025.105380_bib27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.21042","article-title":"Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor","volume":"58","author":"Clark","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jpain.2025.105380_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1744-8069-8-42","article-title":"Anti-hyperalgesic effects of calcitonin on neuropathic pain interacting with its peripheral receptors","volume":"8","author":"Ito","year":"2012","journal-title":"Mol Pain"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jpain.2025.105380_bib30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2967\/jnumed.118.212696","article-title":"Preclinical evaluation and nonhuman primate receptor occupancy study of 18F-JNJ-64413739, a PET radioligand for P2X7 receptors","volume":"60","author":"Kolb","year":"2019","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.jpain.2025.105380_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/glia.10308","article-title":"Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury","volume":"45","author":"Tsuda","year":"2004","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.jpain.2025.105380_bib34","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1523\/JNEUROSCI.23-10-04017.2003","article-title":"p38 Mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain","volume":"23","author":"Jin","year":"2003","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","article-title":"Characterization of cytokine-induced hyperalgesia","volume":"654","author":"Watkins","year":"1994","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.jpain.2025.105380_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","article-title":"Contribution of interleukin-1 to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia","volume":"115","author":"Safieh-Garabedian","year":"1995","journal-title":"Br J Pharmacol"},{"issue":"6827","key":"10.1016\/j.jpain.2025.105380_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/35068566","article-title":"Interleukin-1\u03b2-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity","volume":"410","author":"Samad","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jpain.2025.105380_bib38","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/sj.bjp.0703434","article-title":"Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist","volume":"130","author":"Cunha","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pain.2005.06.009","article-title":"Central cyclooxygenase inhibitors reduced IL-1\u03b2-induced hyperalgesia in temporomandibular joint of freely moving rats","volume":"117","author":"Ahn","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/eujp.2000.0177","article-title":"Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat","volume":"4","author":"Reeve","year":"2000","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0306-4522(94)00549-K","article-title":"Endotoxin-induced appearance of immunoreactive interleukin-1 in ramified microglia in rat brain: a light and electron microscopic study","volume":"65","author":"Van Dam","year":"1995","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(99)00111-6","article-title":"Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?","volume":"83","author":"Field","year":"1999","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neures.2008.10.002","article-title":"Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain","volume":"63","author":"Ikeda","year":"2009","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jpain.2025.105380_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2014.04.003","article-title":"Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine","volume":"735","author":"Le Cudennec","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.jpain.2025.105380_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/j.pain.0000000000001138","article-title":"Sensory profiling in animal models of neuropathic pain: a call for back-translation","volume":"159","author":"Rice","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jpain.2025.105380_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12630-012-9881-7","article-title":"Sex-related differences in acute and chronic pain: a bench to bedside perspective","volume":"60","author":"Mifflin","year":"2013","journal-title":"Can J Anaesth"},{"issue":"1-2","key":"10.1016\/j.jpain.2025.105380_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2005.06.020","article-title":"The case for the inclusion of female subjects in basic science studies of pain","volume":"117","author":"Mogil","year":"2005","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jpain.2025.105380_bib48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2025.105380_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11302-021-09776-9","article-title":"Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer","volume":"17","author":"Drill","year":"2021","journal-title":"Purinergic Signal"},{"issue":"4","key":"10.1016\/j.jpain.2025.105380_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jpain.2025.105380_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","article-title":"Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects","volume":"75","author":"Ali","year":"2012","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025006078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025006078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:39:06Z","timestamp":1780313946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590025006078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S1526590025006078"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105380","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AK1780, a selective P2X7 receptor antagonist with high central nervous system penetration, exhibits analgesic effect in rat neuropathic pain model","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"105380"}}